Arctiin alleviates psoriasis-like dermatitis in association with gut microbiota remodeling and Akkermansia muciniphila enrichment
Year: 2026
Type: article
Abstract: Introduction Psoriasis is a chronic recurrent inflammatory skin disease associated with gut microbiota dysbiosis. Arctiin (ARC), a plant-derived lignan, has anti-inflammatory and microbiota-modulating properties; however, its role in psoriasis remains unclear. Objective To investigate the protective effects of ARC against psoriasis-like dermatitis and the association between these effects and the gut microbiota. Methods Psoriasis-like dermatitis was induced in mice using topical imiquimod. ARC was administered prior to disease induction. Psoriasis-like inflammation was assessed by modified Psoriasis Area and Severity Index (mPASI) scoring, histopathology, immunofluorescence and RT–qPCR. The contribution of the gut microbiota was assessed using antibiotic treatment, fecal microbiota transplantation (FMT), and bacterial supplementation. The gut microbiota composition was analyzed by 16S rRNA gene sequencing. Results ARC markedly alleviated psoriasis-like inflammation, as evidenced by reduced mPASI scores, epidermal hyperplasia, immune cell infiltration and angiogenesis. ARC also decreased the expression of inflammatory mediators in psoriasis-like skin lesions. Antibiotic treatment attenuated the protective effects of ARC, whereas FMT from ARC-treated donors protected recipient mice. 16S rRNA sequencing revealed a reduced abundance of Akkermansia muciniphila (AKK) in psoriasis-like mice; the abundance was partially restored by ARC treatment. Supplementation with AKK partially recapitulated the protective effects of ARC, including the suppression of inflammatory cytokine expression and immune cell infiltration. Conclusion ARC alleviates psoriasis-like dermatitis through the modulation of the gut microbiota and the enrichment of AKK. These findings support a role for microbiota-associated mechanisms in ARC-mediated protection and highlight the potential of ARC as a microbiota-targeted therapeutic strategy for psoriasis.
Source: Frontiers in Immunology
Authors: Mengyao Yang(Conceptualization, Project administration, Writing – original draft), Ge Peng(Conceptualization, Funding acquisition, Resources, Writing – original draft), Alafate Abudouwanli(Visualization, Writing – review & editing), Quan Sun(Methodology, Writing – review & editing), Wanchen Zhao(Software, Writing – review & editing), Shan Wang(Data curation, Validation, Writing – review & editing), Yi Tan(Formal analysis, Writing – review & editing), Hideoki Ogawa(Supervision, Writing – review & editing), Ko Okumura(Supervision, Writing – review & editing), Xinghua Gao(Supervision, Writing – review & editing), François Niyonsaba(Funding acquisition, Supervision, Writing – review & editing)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: arctiin, psoriasis, psoriasis-like dermatitis, gut microbiota, Akkermansia muciniphila, lignans, imiquimod-induced dermatitis, microbiota-targeted therapy, epidermal hyperplasia, immune cell infiltration, angiogenesis, inflammatory cytokines, fecal microbiota transplantation, antibiotic therapy
Open Access status: gold
Estimated APC paid: $3,801
Award: G9001397635
OpenAlex ID: W7236230327
